Between 2020 to 2025, the global cannabis testing market is forecasted to hike at a CAGR of 12.42%. This market was worth USD 1218.0 million in 2020 and is estimated to grow USD 2187.3 million by 2025. In the last few years, the cannabis testing market has evolved from naive exuberance to a steadfast and credible stance that seeks legitimacy in numerous ways. However, government support and companies play an important role in this growth, a lack of professionals drawn the market. Also, seriously impacted by the COVID-19 pandemic, the global demand for the cannabis testing market is projected to rise faster over the next two years. Increased use of cannabinoid testing in medical drugs is expected to fuel consumer demand in the coming years.
Cannabis Testing can be defined as the various drug testing methods for detecting the use of cannabis in an individual in the fields of sport, medicine, and law. There are many ways cannabis use can be seen; some are urine testing, hair testing, blood testing, and saliva testing. Unlike alcohol detection by using breathalyzers, detecting cannabis use by any test takes a considerable amount of time. A few tests like the Duquenois-Levine test can be used for quick detection, but it’s not reliable since it gives false-positive results for many other substances than cannabinoids.
Cannabis testing refers to the analysis of a single cannabis sample that can be tested to determine elements like THC, CBD, and terpene levels and impurities such as residual solvents, mold, diseases, pests, or pesticide residues. Every country imposes its standards and regulations on what needs to be tested and printed on cannabis labels. Individual producers can choose higher standards and go as long as their samples are analyzed for CBC and CBG levels. Certified chemical and laboratory technicians can only perform cannabis testing.
The legalization of cannabis and support from the governments boost the global cannabis testing market.
The increase in the medicinal use of cannabis would stimulate the medical cannabis market, making a favorable effect on the development of the cannabis testing market. Growing drug usage for medicinal reasons has contributed to the legalization of cannabis in different countries worldwide. Legal cannabis is beneficial in numerous medical uses, such as decreasing chemotherapy-related nausea, stimulating appetite in AIDS patients, managing muscle spasms in multiple sclerosis patients, and reducing intraocular pressure in patients with glaucoma. Owing to its medicinal effects, policymakers legalize the use of medical cannabis in different countries.
Also, government support to conduct cannabis testing drives the cannabis testing market growth. The trend of appropriation of the cannabis test measure is expanding. A few government departments are conducting laboratory studies on cannabis products needed to support the growth of the cannabis industry. Numerous regulatory bodies have started to place overall restrictions on residual solvents, bug sprays, contaminants, heavy metals, microorganisms, and mycotoxins for plant testing. It also led to the establishment of numerous new laboratories, particularly in locations where growth is at its height.
Furthermore, growing awareness and adoption of LIMS in labs testing cannabis is another factor boosting the market. Strict federal guidelines for safety testing must be met by prescription distributors before opioid use and expands understanding of cannabis by promotions, seminars, and workshops. Increased discovery and production of a potential therapeutic medication for chronic disorders by major healthcare companies and increased use of cannabis in leisure and personal use are further adding to the expansion of the worldwide demand for cannabis testing.
Increasing economies of developing countries in APAC and the Middle East region are expected to increase opportunities for the stakeholders operating in these regions. The need for more testing laboratories to meet the demand of growing cannabis producers across the world is likely to create opportunities for the cannabis testing market during the forecast period.
Among various testing methods, cannabis usage by taking urine samples can be detected up to 2-5 days after exposure in infrequent users and up to 15 days in heavy users. Through saliva testing, usage can be detected in a short time window of only three days, but the advantage is that it can detect compounds with concentrations of less than 0.5 ng/mL. Though blood testing is not frequently used as the procedure is invasive, it can detect usage within 12-24 hours window in infrequent users and seven days in heavy users. Hair testing has the special feature of detecting use even after 90 days of exposure and can detect concentrations as low as one pg/mg of sample.
The factors limiting the growth of the cannabis testing market are the high cost of analytical instruments, lack of specialized laboratories, high start-up costs for cannabis testing laboratories, lack of industry standards for cannabis testing, and high cost of installing a cannabis test facility.
Furthermore, the lack of trained experts in the area of cannabis testing is one of the main issues facing the industry for cannabis testing. If the legal cannabis industry begins to expand, the demand for laboratory-tested cannabis will also increase. The initial cost to set up cannabis testing labs and the cost involved in the cannabis testing instruments is very high. The basic criteria to be met require the testing instrument, inventory control, quality control, trained employees, data management, and administrative functions to set up a research facility. Also, the lack of uniform test requirements would further impede the development of the future demand for cannabis testing.
Moreover, new entrants are investing in cannabis testing industries due to favorable government funding, shortage of providers, and manufacturers in developing markets are providing attractive growth prospects for the cannabis testing market in the coming years.
COVID-19 is an infectious disease caused by the most recent novel coronavirus. As the World Health Organisation (WHO) publicly proclaimed the spread of the virus to be a pandemic, a combination of established pharmaceutical firms and small start-ups have come in to produce drugs and vaccines. The unexpected emergence of the COVID-19 pandemic has positively and negatively affected the pharmaceutical and life sciences industries.
Diminishing growth in pandemic
The effects of the pandemic and the winding down of global science activities have harmed the operations and financial results of many industry participants, such as the cannabis testing market. Leading to the closing of university and scientific institutes and testing labs, there has been a reduction in the number of cannabis experiments conducted in laboratories. These laboratories that were entirely or partly open operated primarily on the COVID-19 test instead of the normal activities.
The cannabis testing market has lost some sales due to reasons such as store closing, laboratory closures, destruction to supply chains, general economic downturn, and limited movement. Also, numerous business players supplying goods and software to the cannabis testing market have experienced a decrease in the selling of equipment and consumables due to the closure of laboratories, the decline in the number of cannabis tests conducted, and some limitations on the import and export of cannabis testing products. These trends have led to a decrease in the consumables and equipment used in the cannabis testing market, which has slowed the growth of the market.
Cannabis can be an effective treatment for COVID-19.
Many positive influences of COVID-19 are also seen in the development of the demand for cannabis testing. More recently, a collaboration between the University of Lethbridge in Alberta, Canada, and Pathway RX and Swysh Inc. Cannabis testing companies discovered that some Cannabis sativa extracts might be used in therapies to prevent infection with SARS-CoV-2, the virus that causes COVID-19. The researcher also says that CBD, a non-intoxicating cannabinoid (chemical compound) present in cannabis ingredients, can help reduce the cytokine storm and the severe inflammation of the lungs caused by Covid-19.
Market Size Available
2019 to 2025
2020 to 2025
By Testing Procedures, End User, Product & Software and Region
Various Analyses Covered
Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities
North America, Europe, Asia Pacific, Latin America, Middle East, and Africa
This research report on the global cannabis testing market has been segmented and sub-segmented testing procedures, end-users, products & software, and region.
Cannabis Testing Market - By Testing Procedures:
Based on the testing procedure, In 2019 year, the potency testing segment accounted for the largest share and predicted to grow at a CAGR of 21.7% from 2020 to 2025 due to the presence of contributing factors such as a rise in the usage of effective potency testing techniques like GC (Gas Chromatography) and HPLC (High-performance Liquid Chromatography) to test samples, growth in demand to examine the potency of various cannabinoids especially CBD (Cannabidiol), and THC (Tetrahydrocannabinol) in the cultivation of cannabis.
Cannabis Testing Market - By End-user:
Based on end-user, the cannabis laboratories segment accounts for the largest market share in this segment due to the rising demand for cannabis testing software in labs. The Cannabis laboratories market segment is dominating the global market. It is expected to grow rapidly during the forecast period due to the escalation of legalization procedures to use cannabis for medical and recreational purposes worldwide. Various authorities' stringent regulations to ensure superior quality cannabis products and patient safety are increasing cannabis testing lab activities, eventually resulting in the growth of the cannabis testing market during the forecast period.
The segment of cannabis cultivators is expected to showcase promising growth during the forecast period and is predicted to register a CAGR of 59.4% between 2020 to 2025. This segment is strongly driven by the factors such as the rise in the research activities, growth in the numerous research centers, and laboratories by government and private in numerous countries by imposing strict rules and regulations on the THC content cannabis products.
During the forecast period, the cannabis drug manufacturers segment is forecasted to exhibit a healthy CAGR due to the rise of acceptance rate and numerous clinical trial centers by large key players such as Solvay pharmaceutical, Sanofi, and Pfizer.
Cannabis Testing Market - By Product & Software:
Cannabis Testing Market - By Region:
Geographically, North America had the leading share in the global cannabis testing market, accounting for around 34%, and is also the fastest-growing market. The North American market is majorly supported by the increase in the number of testing laboratories, the government's growth of guidelines for cultivators of marijuana, and the presence of a large number of cultivators. Europe follows North America in share. Developing countries in the Asia-Pacific region are expected to witness the highest growth rate going based on the country. Growing awareness about drug testing and reduction in prices are the major driving factors in these countries.
KEY MARKET PARTICIPANTS AND SHARE INSIGHTS:
Some of the notable participants leading the global cannabis testing market profiled in this report are Agilent Technologies, Inc., Shimadzu Corporation, Waters Corporation, PerkinElmer, Inc., AB SCIEX LLC, Millipore Sigma, Restek Corporation, LabLynx, Inc. (U.S.), Steep Hill Labs, Inc., PharmLabs, LLC, SC Laboratories, Inc., Digipath Labs, Inc., CannaSafe Analytics, Accelerated Technology Laboratories, Inc.
These business leaders have adopted different tactics, such as mergers and acquisitions, alliances, accreditations, etc., intending to secure a high share of sales in the cannabis testing market. For example, on 29 January 2021, MCR Labs, a Massachusetts-based cannabis testing firm, has recently opened a laboratory in Allentown and has started to approve and analyze product samples for medical marijuana licensees.
In January 2019, Digipath, Inc. announced an agreement with cannabis, Inc. to increase its market share in the cannabis test and strengthen its position in the domestic and international cannabis testing market.
In January 2019, Anandia Laboratories announced the inauguration of the Cannes Innovation Center (CIC) to develop cannabis using modern plant breeding tools. This facility will allow the company to expand its product portfolio and customer base.
In March 2017, Shimadzu Company launched a cannabis analyzer for cannabinoid testing. The instrument is based on a chromatography technique and offers high performance, high sensitivity, and high resolution. Various technological developments will stimulate the adoption of chromatography techniques for cannabis testing resulting in the growth of the cannabis testing market over the forecast period.
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product & Software
5.1.1 Analytical Instruments
18.104.22.168 Chromatography Instruments
22.214.171.124.1 Liquid Chromatography
126.96.36.199.2 Gas Chromatography
188.8.131.52.3 Other Chromatography Instruments
184.108.40.206 Spectroscopy Instruments
220.127.116.11.1 Atomic Spectrometry Instruments
18.104.22.168.2 Mass Spectroscopy Instruments
22.214.171.124 Other Analytical Instruments
126.96.36.199 Sample Preparation Products
188.8.131.52 Standards and CRMS
184.108.40.206 Chromatography Columns
220.127.116.11 Supplies and Accessories
5.1.5 Y-o-Y Growth Analysis, By Product & Software
5.1.6 Market Attractiveness Analysis, By Product & Software
5.1.7 Market Share Analysis, By Product & Software
5.2 Testing Procedures
5.2.1 Terpene Profiling
5.2.2 Potency Testing
5.2.3 Residual Solvent Screening
5.2.4 Pesticide Screening
5.2.5 Genetic Testing
5.2.6 Heavy Metal Testing
5.2.7 Microbial Analysis
5.2.8 Y-o-Y Growth Analysis, By Testing Procedures
5.2.9 Market Attractiveness Analysis, By Testing Procedures
5.2.10 Market Share Analysis, By Testing Procedures
5.3 End Users
5.3.1 Cannabis Cultivators
18.104.22.168 Small-Scale Laboratories
22.214.171.124 Medium-Scale Laboratories
126.96.36.199 Large-Scale Laboratories
5.3.3 Drug Manufacturers & Dispensaries
5.3.4 Research Institutes
5.3.5 Y-o-Y Growth Analysis, By End Users
5.3.6 Market Attractiveness Analysis, By End Users
5.3.7 Market Share Analysis, By End Users
6. Geographical Analysis
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
188.8.131.52 By Product & Software
184.108.40.206 By Testing Procedures
220.127.116.11 By End Users
6.1.4 Market Attractiveness Analysis
18.104.22.168 By Product & Software
22.214.171.124 By Testing Procedures
126.96.36.199 By End Users
6.1.5 Market Share Analysis
188.8.131.52 By Product & Software
184.108.40.206 By Testing Procedures
220.127.116.11 By End Users
6.2 North America
6.1.2 United States
6.3.6 South Korea
6.5 Latin America
6.4.5 Rest of Latin America
6.6 Middle East & Africa
7.1 PESTLE analysis
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Agilent Technologies Inc.
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Shimadzu Corporation
8.3 Waters Corporation
8.4 PerkinElmer Inc.
8.5 AB SCIEX LLC
8.6 Millipore Sigma
8.7 Restek Corporation
8.8 LabLynx Inc. (U.S.)
8.9 Steep Hill Labs Inc.
8.10 PharmLabs LLC
8.11 SC Laboratories Inc.
8.12 Digipath Labs Inc.
8.13 CannaSafe Analytics
8.14 Accelerated Technology Laboratories Inc.
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
a) List of Tables
b) List of Figures